Industry reports
Editor highlights

Publication dates

All regions

Cancer Research Reports, April 2014

You might be interested in: medical equipment, therapeutics, prostate cancer, more »


 

1-20 of about 141 000 reports for Cancer
Refractory Acute Myeloid Leukemia Global Clinical Trials Review, H1, 2014

Refractory Acute Myeloid Leukemia Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • April 2014
  • by Global Data

... Cornerstone pharmaceuticals lead compound cpi-613 demonstrates ability to disrupt growth of cancer cells 32jun 25, 2013: fda issues partial clinical hold on cell therapeutics's tosedostat for treatment ...

Metastatic Colorectal Cancer Global Clinical Trials Review, H1, 2014

Metastatic Colorectal Cancer Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • April 2014
  • by Global Data

... Relating to the clinical trials on metastatic colorectal cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2014

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • April 2014
  • by Global Data

... Provides briefing pertaining to the number of trials for the key drugs for treating metastatic hormone refractory (castration resistant, androgen-independent) prostate cancer. This report is built using data ...

Metastatic Ovarian Cancer Global Clinical Trials Review, H1, 2014

Metastatic Ovarian Cancer Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • April 2014
  • by Global Data

... To the clinical trials on metastatic ovarian cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary ...

Metastatic Prostate Cancer Global Clinical Trials Review, H1, 2014

Metastatic Prostate Cancer Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • April 2014
  • by Global Data

... To the clinical trials on metastatic prostate cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers ...

Metastatic Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014

Metastatic Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • April 2014
  • by Global Data

... Metastatic renal cell carcinoma therapeutics clinical trials market, global, clinical trials by memorial sloan kettering cancer center, 2014* 68metastatic renal cell carcinoma therapeutics clinical trials market ...

Metastatic Transitional (Urothelial) Tract Cancer Global Clinical Trials Review, H1, 2014

Metastatic Transitional (Urothelial) Tract Cancer Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • April 2014
  • by Global Data

... Provides briefing pertaining to the number of trials for the key drugs for treating metastatic transitional (urothelial) tract cancer. This report is built using data and information sourced from proprietary ...

Metastatic Transitional Cell Cancer (Urothelial Cell Cancer) Global Clinical Trials Review, H1, 2014

Metastatic Transitional Cell Cancer (Urothelial Cell Cancer) Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • April 2014
  • by Global Data

... Urothelial cell cancer). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease ...

Oral Cavity (Mouth) Cancer Global Clinical Trials Review, H1, 2014

Oral Cavity (Mouth) Cancer Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • April 2014
  • by Global Data

... To the clinical trials on oral cavity (mouth) cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers ...

Carbohydrate Antigens Test Systems for Pancreatic Cancer - Medical Device Safety and Approval Report - Comprehensive

Carbohydrate Antigens Test Systems for Pancreatic Cancer - Medical Device Safety and Approval Report - Comprehensive

  • $ 199
  • Industry report
  • April 2014
  • by DeviceMatters

... Carbohydrate antigens test systems for pancreatic cancer - medical device safety and approval report - comprehensive the comprehensive devicematters medical device safety and approval report provides ...


» Read our Company Profiles

72 Companies for Cancer

Novartis Inc.

Switzerland

GlaxoSmithKline P.L.C.

United States

Cepheid

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.